3rd Quarter - Report

TALLEY STRATEGIES LLC for TEVA PHARMACEUTICALS USA, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to pharmaceutical drug pricing (no specific legislation).

Foreign entity interest: Client is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., as disclosed on the lobbying registration, and as such would benefit from similar opportunities as Client.

LobbyistCovered position, as disclosed
AMBER TALLEY New Senior Counsel/Investigator, Senate Special Committee on Aging; Legislative Director, Chief of Staff, Rep. Jason Chaffetz; Counsel, House Oversight Committee

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues related to pharmaceutical drug pricing (no specific legislation).

Foreign entity interest: Client is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., as disclosed on the lobbying registration, and as such would benefit from similar opportunities as Client.

LobbyistCovered position, as disclosed
AMBER TALLEY New Senior Counsel/Investigator, Senate Special Committee on Aging; Legislative Director, Chief of Staff, Rep. Jason Chaffetz; Counsel, House Oversight Committee

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.